A qualitative study exploring barriers and facilitators for reporting of adverse drug reactions (ADRs) among community pharmacists in Malaysia

Journal of Pharmaceutical Health Services Research

Volumn 2, Issue 2, 2011, Pages 71-78

  Elkalmi, Ramadan Mohamed ^a   Hassali, Mohamed Azmi ^a   Ibrahim, Mohamed Izham M ^a   Liau, Siow Yen ^a   Awaisu, Ahmed ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Adverse drug reactions reporting; Community pharmacy; Malaysia; Pharmacovigilance

Indexed keywords

ADULT; ARTICLE; CONTINUING EDUCATION; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; INTERVIEW; MALAYSIA; MALE; MEDICAL EDUCATION; PHARMACIST ATTITUDE; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; QUALITATIVE RESEARCH; VOLUNTARY REPORTING;

EID: 84860389093     PISSN: 17598885     EISSN: 17598893     Source Type: Journal    
DOI: 10.1111/j.1759-8893.2011.00037.x     Document Type: Article

References (49)

1. MADRAC. Malaysian Guidelines for the Reporting and Monitoring of ADR. Kuala Lumpur, 2002 (accessed 25 November 2010).
2. MADRAC. Activities of MADRAC for 2009. Kuala Lumpur, National Pharmaceutical Control Bureau, Ministry of Health Malaysia; 2010.
3. Van Grootheest A, De Jong-van den Berg L. Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting. Int J Pharm Pract 2002; 10: 267-272.
4. Pirmohamed MBA etal. Adverse drug reactions. Br Med J 1998; 316: 1295-1298.
5. Lindquist M. Data quality management in pharmacovigilance. Drug Saf 2004; 27: 857-870.
6. World Health Organization. Safety of Medicines - a Guide to detecting and reporting adverse drug reactions. Geneva: World Health Organization, 2002.
7. Lazarou J etal. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-1205.
8. Pirmohamed M etal. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. Br Med J 2004; 329: 15-19.
9. Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993; 27: 832-840.
10. Mjorndal T etal. Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf 2002; 11: 65-72.
11. Fletcher A. Spontaneous adverse drug reaction reporting vs event monitoring: a comparison. J R Soc Med 1991; 84: 341-344.
12. Editorial. Improving ADR reporting. Lancet 2002; 360: 1435.
13. Zolezzi M, Parsotam N. Adverse drug reaction reporting in New Zealand: implications for pharmacists. Ther Clin Risk Manag 2005; 1: 181-188.
14. Backstorm M. Spontaneous reporting of adverse drug reactions possibilities and limitations: Umeå University. 2005.
15. Rawlins M. Spontaneous reporting of adverse drug reactions. I: the data. Br J Clin Pharmacol 1988; 26: 1-5.
16. Backstrom M etal. Attitudes to reporting adverse drug reactions in northern Sweden. Eur J Clin Pharmacol 2000; 56: 729-732.
17. Wiholm BE etal. Spontaneous reporting systems outside the US. In: Brian LS, ed. Pharmacoepidemiology, 3rd edn. Chichester: John Wiley & Sons. 2000: 175-192.
18. Clarke A etal. An assessment of the publicly disseminated evidence of safety used in decisions to withdraw medicinal products from the UK and US markets. Drug Saf 2006; 29: 175-181.
19. Inman WHW. Attitudes to adverse drug reaction reporting. Br J Clin Pharmacol 1996; 41: 434.
20. Herdeiro MT etal. Influence of pharmacists' attitudes on adverse drug reaction reporting: a case-control study in Portugal. Drug Saf 2006; 29: 331-340.
21. Belton KJ etal. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. J Clin Pharmacol 1995; 39: 223-226.
22. Bateman DN etal. Attitudes to adverse drug reaction reporting in the Northern Region. Br J Clin Pharmacol 1992; 34: 421-426.
23. Vallano A etal. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol 2005; 60: 653.
24. Hazell L, Shakir S. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 29: 385-396.
25. Irujo M etal. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Drug Saf 2007; 30: 1073-1082.
26. Aziz Z etal. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia. Pharmacoepidemiol Drug Saf 2007; 16: 223-228.
27. Enwere O etal. Adverse drug reactions reporting by physicians in Ibadan, Nigeria. Pharmacoepidemiol Drug Saf 2008; 17: 517-522.
28. Haq A. Pharmacovigilance initiatives in Malaysia. Drug Inf J 2003; 37: 143(S)-148(S).
29. Bartos R, Lazarsfeld PF. Understanding Qualitative Research. New York: Advertising Research Council, 1992.
30. Raymond O. Advantages and disadvantages of four interview techniques in qualitative research. 2006.
31. Kairuz T etal. An overview of qualitative research. Pharm J 2007; 277: 312-314.
32. Veale B. Does it matter that your research is qualitative? Aust Fam Physician 1999; 28: 537-538.
33. Ezzy D. Politics, Rigour and Ethics: Qualitative Analysis: Practice and Innovation. Sydney: Allen and Unwin, 2002.
34. Dahlgren LFM. Phenomenography as a qualitative approach in social pharmacy research. J Soc Adm Pharm 1991; 8: 150-156.
35. Strauss AL, Glaser BG. The Discovery of Grounded Theory: Strategies for Qualitative Research. New York: Aldine Publishing Co, 1967.
36. Lee KK etal. Pharmacists' attitudes toward adverse drug reaction reporting in Hong Kong. Ann Pharmacother 1994; 28: 1400-1403.
37. Eland IA etal. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol 1999; 48: 623-627.
38. Hasford J etal. Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol 2002; 55: 945-950.
39. Van Grootheest K etal. Pharmacists' role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf 2004; 13: 457-464.
40. Green CF etal. Community pharmacists' attitude to adverse drug reaction reporting. Int J Pharm Pract 1999; 7: 92-99.
41. Grootheest AC etal. Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting. Int J Pharm Pract 2002; 10: 267-272.
42. Gossell-Williams M, Adebayo SA. The PharmWatch programme: challenges to engaging the community pharmacists in Jamaica. Pharm Pract (Internet) 2008; 6: 187-190.
43. Toklu HZ, Uysal MK. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci 2008; 30: 556-562.
44. Herdeiro MT etal. Factors that influence spontaneous reporting of adverse drug reactions: a model centralized in the medical professional. J Eval Clin Pract 2004; 10: 483.
45. Green CF etal. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol 2001; 51: 81-86.
46. Vessal G etal. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran. Pharm World Sci 2008; 31: 183-187.
47. Bawazir SA. Consumer attitudes towards community pharmacy services in Saudi Arabia. Int J Pharm Pract 2004; 12: 83-89.
48. van Grootheest K etal. Underreporting in the spontaneous reporting of adverse drug reactions - a pharmacovigilance approach. In: van Grootheest AC, ed. Improving Pharmacovigilance and the Role of the Pharmacist. Groningen: University Library Groningen, 2003: 65-79.
49. Pedros C etal. An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain. Drug Saf 2009; 32: 77-83.